Rabies DNA vaccine in the horse: Strategies to improve serological responses

Vaccine

Volumn 21, Issue 31, 2003, Pages 4593-4596

  Fischer, Laurent ^a   Minke, Jules ^a   Dufay, Nathalie ^a   Baudu, Philippe ^a   Audonnet, Jean Christophe ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

DNA vaccine; Horse; Rabies

Indexed keywords

ALUMINUM PHOSPHATE; DNA VACCINE; LIPID; RABIES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG POTENTIATION; HORSE; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RABIES; SEROCONVERSION; VACCINATION;

EID: 0142199967     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00504-8     Document Type: Article

References (27)

1. Wolff J.A., Malone R.W., Williams P.et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
2. Tang D.C., De Vit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
3. Robinson H.L., Hunt L.A., Webster R.G. Protection against lethal influenza challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 11:1993;957-960.
4. Robinson H.L. DNA vaccines: basic mechanism and immune responses (review). Int. J. Mol. Med. 4:1999;549-555.
5. Kodihalli S., Goto H., Kobasa D.L., Krauss S., Kawaoka Y., Webster R.G. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73:1999;2094-2098.
6. Konishi E, Yamaoka M, Khin-Sane-Win, Kurane I, Takada K, Mason PW. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus pre-membrane and envelope genes. J Virol 1999;73:5527-34.
7. Johnson P.A., Conway M.A., Daly J., Nicolson C., Robertson J., Mills K.H. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J. Gen. Virol. 81:2000;1737-1745.
8. Otten G.R., Doe B., Schaefer M.et al. Relative potency of cellular and humoral immune responses induced by DNA vaccination. Intervirology. 43:2000;227-232.
9. Wang R., Doolan D.L., Le T.P.et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science. 282:1998;476-480.
10. Somasundaram C., Takamatsu H., Andreoni C.et al. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. Vet. Immmunol. Immunopathol. 70:1999;277-287.
11. Drew D.R., Boyle J.S., Lew A.M., Lightowlers M.W., Chaplin P.J., Strugnell R.A. The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep. Vaccine. 19:2001;4417-4428.
12. Green T.D., Newton B.R., Rota P.A., Xu Y., Robinson H.L., Ross T.M. C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine. 20:2001;242-248.
13. Lunn D.P., Soboll G., Schram B.R.et al. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine. 17:1999;2245-2258.
14. Ulmer J.B., DeWitt C.M., Chastain M.et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine. 18:1999;18-28.
15. Sasaki S., Tsuji T., Hamajima K.et al. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect. Immun. 65:1997;3520-3528.
16. Lodmell D.L., Ray N.B., Ulrich J.T., Ewalt L.C. DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL). Vaccine. 18:2000;1059-1066.
17. Hartikka J., Bozoukova V., Ferrari M.et al. Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. Vaccine. 19:2001;1911-1923.
18. Xiang Z.Q., Spitalnik S.L., Cheng J., Erikson J., Wojczyk B., Ertl H.C.J. Immune response to nucleic acid vaccines to rabies virus. Virology. 209:1995;569-579.
19. Perrin P., Jacob Y., Aguilar-Setien A.et al. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine. 18:1999;479-486.
20. Osorio J.E., Tomlinson C.C., Frank R.S.et al. Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine. 17:1999;1109-1116.
21. Lodmell D.L., Ray N.B., Parnell M.J., Ewalt L.C., Hanlon C.A., Shaddock J.H.et al. DNA immunization protects non-human primates against rabies virus. Nat. Med. 4:1998;949-979.
22. Daniels G.A., Galanis E. Immunotherapy of renal cell carcinoma by intratumoral administration of an IL-2cDNA/DMRIE/DOPE lipid complex. Curr. Opin. Mol. Ther. 3:2001;70-76.
23. Stopeck A.T., Jones A., Hersh E.M.et al. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. Clin. Cancer Res. 7:2001;2285-2291.
24. Hartikka J., Sawdey M., Cornefert-Jensen F.et al. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum. Gene Ther. 7:1996;1205-1217.
25. Klavinskis L.S., Barnfield C., Gao L., Parker S. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J. Immunol. 162:1999;254-262.
26. Blasco E., Lambot M., Barrat J., Cliquet F., Brochier B., Renders C.et al. Kinetics of humoral immune response after rabies VR-G oral vaccination of captive fox cubs (Vulpes vulpes) with or without maternally derived antibodies against the vaccine. Vaccine. 19:2001;4805-4815.
27. Davis B.S., Chang G.J., Cropp B., Roehrig J.T., Martin D.A., Mitchell C.J.et al. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vivo a non-infectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75:2001;4040-4047.